Magpie Pharmaceuticals
China - GuangzhouPharmaceutical
Focus: Magpie Pharmaceuticals is a China-based company focused on modernizing traditional Chinese medicines, with current expertise concentrated in neurology.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Magpie Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Magpie Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MN-08 24 mg/day
Pulmonary Arterial HypertensionClinical Trials (1)
NCT05660863A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets
Phase 1Help build intelligence for Magpie Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.